Urinary Tract Infection Vaccine

This study is currently active

Phase 3 vaccine to prevent invasive E.coli infection the leading bacteria in urinary tract infections. Ages 60 and over both male and females that have had at least one urinary tract infection in the last two years. Documentation of the UTI will be required prior to vaccination. The study will last two years with 8 office visits to the clinic. Compensation for time and travel will be provided up to $600.

Participate in a Study

Submit the form and a clinical study expert will get in touch with you.

Want to know more about our clinical trials?